Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Seer Inc Cl A (NQ: SEER )

1.915 -0.025 (-1.29%)
Streaming Delayed Price Updated: 1:24 PM EDT, Oct 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 112,336
Open 1.910
Bid (Size) 1.910 (125)
Ask (Size) 1.920 (37)
Prev. Close 1.940
Today's Range 1.900 - 1.920
52wk Range 1.455 - 2.300
Shares Outstanding 65,088,575
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
From Seer, Inc.
Via GlobeNewswire
Seer Appoints Nicolas Roelofs to its Board of Directors
From Seer, Inc.
Via GlobeNewswire

Performance

YTD
-1.29%
-1.29%
1 Month
+14.67%
+14.67%
3 Month
+16.77%
+16.77%
6 Month
+8.19%
+8.19%
1 Year
-13.74%
-13.74%

More News

Read More
Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference
From Seer, Inc.
Via GlobeNewswire
SEER Stock Earnings: Seer Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Recap: Seer Q4 Earnings
Via Benzinga
Earnings Scheduled For February 29, 2024
Via Benzinga
Seer Reports Second Quarter 2024 Financial Results
From Seer, Inc.
Via GlobeNewswire
Seer to Report Second Quarter 2024 Financial Results on August 8, 2024
From Seer, Inc.
Via GlobeNewswire
Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery
From Seer, Inc.
Via GlobeNewswire
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Early Cancer Detection Study
From Seer, Inc.
Via GlobeNewswire
SEER Stock Earnings: Seer Meets EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Seer Reports First Quarter 2024 Financial Results
From Seer, Inc.
Via GlobeNewswire
Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic Solutions
From Seer, Inc.
Via GlobeNewswire
Seer to Report First Quarter 2024 Financial Results on May 8, 2024
From Seer, Inc.
Via GlobeNewswire
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
From Seer, Inc.
Via GlobeNewswire
Seer to Participate in the TD Cowen 44th Annual Health Care Conference
From Seer, Inc.
Via GlobeNewswire
Zoom Video And 2 Other Stocks Insiders Are Selling
Via Benzinga
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
From Seer, Inc.
Via GlobeNewswire
Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
From Seer, Inc.
Via GlobeNewswire
Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference
From Seer, Inc.
Via GlobeNewswire
Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
From Seer, Inc.
Via GlobeNewswire
Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500
From Seer, Inc.
Via GlobeNewswire
Seer Reports Third Quarter 2023 Financial Results
From Seer, Inc.
Via GlobeNewswire
Seer Announces Addition of Panome Bio to Centers of Excellence (COE) Program
From Seer, Inc.
Via GlobeNewswire
Earnings Scheduled For November 7, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.